Everything about most clinical trials/studies that gets off the ground is "positive trending" and/or "strong signals". It was that for Topline Data from the COVID Romania "study" until it wasn't in the Final Data readout (zero signal). IMO, you continue to ignore the FACT there were no statistically significant signals in any "study" thus far. That remains true with the vague unveiling of the AU/NZ Chronic Cough data.
tcm55
How about reserving full judgement about data until we actually get to see it?
I misspoke in a previous post today about the pending standalone CC clinical trial. My concern about that is whether or no it will be a clinical trial a Phase 2 clinical trial designed to move to Phase 3 or will it be a powered to move to another Phase 2 for efficacy versus safety/dosing? That's my #2 concern and ridding conflicts of interest is #1.